1. Safety and Disease Evolution of Fixed-Dose Combination of Antitubercular Treatment Compared to Separate-Drugs Preparation in Extra-Pulmonary Tuberculosis

   • Houda Ben Ayed
   • Makram Koubaa
   • Mounir Ben Jemaa

   Commentary 16 August 2018 Pages: 415 - 421

2. Using Human Induced Neural Precursor Cells to Define Early Neurodevelopmental Defects in Syndromic and Idiopathic Autism

   • Robert J. Connacher
   • Emanuel DiCicco-Bloom
   • James H. Millonig

   Neurogenesis and Disease (L Cai, Section Editor) 29 August 2018 Pages: 422 - 435

   

3. Traditional Chinese Medicine in Multiple Sclerosis: Theory and Practice

   • Hao Chen
   • Xiaomeng Ma
   • Xiaohong Chen

   Neuropharmacology (R Pi, Section Editor) 03 September 2018 Pages: 436 - 446

   

4. Therapeutic Connection Between Black Tea Theaflavins and Their Benzotropolone Core Structure

   • Alexander Gosslau
   • Shiming Li
   • Chi-Tang Ho

   Natural Products: From Chemistry to Pharmacology (C-T Ho, Section Editor) 28 August 2018 Pages: 447 - 452

   

5. Epigenetic Effects of the 13 Vitamins

   • Shu-Jie Huang
   • Yan-Ming Xu
   • Andy T. Y. Lau

   Epigenetics (ATY Lau, Section Editor) 21 September 2018 Pages: 453 - 467

6. The Anticancer and Chemopreventive Activity of Selenocyanate-Containing Compounds

   • Wesam Ali
   • Mónica Álvarez-Pérez
   • Enrique Domínguez-Álvarez

   Redox Modulators (C Jacob, Section Editor) 24 September 2018 Pages: 468 - 481

   

7. Oxidative Stress and Bladder Cancer Carcinogenesis: Early Detection and Chemoprevention Involving Nrf2—an Integrative Approach

   • Constance Lay Lay Saw

   Cancer Chemoprevention (R Agarwal, KE Bayoumy and S Yu, Section Editors) 20 October 2018 Pages: 482 - 490

   

8. Pediatric Physiologically Based Pharmacokinetic Model Development: Current Status and Challenges

   • Wen Lin
   • Jing-He Yan
   • Handan He

   Pharmacometrics (A Charkraborty, Section Editor) 04 December 2018 Pages: 491 - 501